These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18442305)

  • 1. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
    Cohn SE; Umbleja T; Mrus J; Bardeguez AD; Andersen JW; Chesney MA
    AIDS Patient Care STDS; 2008 Jan; 22(1):29-40. PubMed ID: 18442305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
    Teixeira C; Dourado Mde L; Santos MP; Brites C
    AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term postpartum adherence to antiretroviral drugs among women in Latin America.
    Kreitchmann R; Coelho DF; Kakehasi FM; Hofer CB; Read JS; Losso M; Haberer JE; Siberry GK; Harris DR; Yu Q
    Int J STD AIDS; 2016 Apr; 27(5):377-86. PubMed ID: 25931238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states.
    Wilson TE; Ickovics JR; Fernandez MI; Koenig LJ; Walter E;
    Am J Obstet Gynecol; 2001 May; 184(6):1235-40. PubMed ID: 11349194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.
    Mellins CA; Chu C; Malee K; Allison S; Smith R; Harris L; Higgins A; Zorrilla C; Landesman S; Serchuck L; Larussa P
    AIDS Care; 2008 Sep; 20(8):958-68. PubMed ID: 18608073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine.
    Bailey H; Thorne C; Malyuta R; Townsend CL; Semenenko I; Cortina-Borja M;
    BMC Public Health; 2014 Sep; 14():993. PubMed ID: 25248469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
    Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
    AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ante- and postpartum substance abuse treatment and antiretroviral therapy among HIV-infected women on Medicaid.
    Warner LA; Wei W; McSpiritt E; Sambamoorthi U; Crystal S
    J Am Med Womens Assoc (1972); 2003; 58(3):143-53. PubMed ID: 12948105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level and determinants of postpartum adherence to antiretroviral therapy in the Eastern Cape, South Africa.
    Adeniyi OV; Ajayi AI
    PLoS One; 2020; 15(2):e0229592. PubMed ID: 32106255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV.
    Sheth SS; Coleman J; Cannon T; Milio L; Keller J; Anderson J; Argani C
    AIDS Care; 2015; 27(3):350-4. PubMed ID: 25616659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antiretrovirals among US women during and after pregnancy.
    Bardeguez AD; Lindsey JC; Shannon M; Tuomala RE; Cohn SE; Smith E; Stek A; Buschur S; Cotter A; Bettica L; Read JS;
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):408-17. PubMed ID: 18614923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Illicit drug use by pregnant women infected with HIV].
    Melo VH; Botelho AP; Maia MM; Correa MD; Pinto JA
    Rev Bras Ginecol Obstet; 2014 Dec; 36(12):555-61. PubMed ID: 25466814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Reported Side Effects and Adherence to Antiretroviral Therapy in HIV-Infected Pregnant Women under Option B+: A Prospective Study.
    Phillips T; Cois A; Remien RH; Mellins CA; McIntyre JA; Petro G; Abrams EJ; Myer L
    PLoS One; 2016; 11(10):e0163079. PubMed ID: 27760126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.
    Turner BJ; Newschaffer CJ; Zhang D; Cosler L; Hauck WW
    Med Care; 2000 Sep; 38(9):911-25. PubMed ID: 10982113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
    Bucek A; Leu CS; Benson S; Warne P; Abrams EJ; Elkington KS; Dolezal C; Wiznia A; Mellins CA
    Pediatr Infect Dis J; 2018 Jul; 37(7):673-677. PubMed ID: 29227462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
    Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
    Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.
    Vaz MJ; Barros SM; Palacios R; Senise JF; Lunardi L; Amed AM; Castelo A
    Int J STD AIDS; 2007 Jan; 18(1):28-32. PubMed ID: 17326859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.